Steve B. Ludbrook PhD

Steve B. Ludbrook is a Director at Bicycle Therapeutics, Cambridge, England, United Kingdom. He has led numerous groups across the target validation to clinical candidate selection continuum, supporting a variety of therapeutic areas. Steve currently leads a group in the Biological Sciences division at GSK, supporting reagent supply, assay development, and compound profiling predominantly during the target-to-candidate phase of drug discovery. A particular focus is to combine physiological knowledge with emerging enabling technologies, to deliver medium to high throughput primary cell-based phenotypic assays that better link clinical efficacy to cellular compound screening.